Skip to main content
An image of one of our staff members sitting at 3 computer screens using a driving simulator.  His hands are on a driving wheel attached to the simulator.
Research_

Driving

As medical cannabis becomes more readily available, it is imperative that any risks relating to driving are clarified via thorough research
Our research on medical cannabis and driving is contributing to the ongoing policy debate regarding issues such as safety, impairment and detection.

Our Research


Exploring the effects of THC and CBD on simulated driving

This study explores the idea that CBD content in cannabis plant material will modify the effects of THC on driving, and investigates the link between concentrations of cannabinoids in blood and saliva, and driving ability. Drug testing of saliva and blood follows current Australian police procedures. A secondary aim of the study is to examine the relationship between positive results on these tests and actual driving impairment, currently a very controversial topic in the community and in legal circles.

This is a collaboration between The Lambert Initiative at the University of Sydney, Royal Prince Alfred Hospital and Tilray.

Chief Investigators: Professor Iain McGregor (Lambert Initiative, University of Sydney)

Project Coordinator: Thomas Arkell (Lambert Initiative, University of Sydney)


On road driving with THC and CBD

Experimental studies indicate that cannabis causes dose-dependent impairment in driving performance and associated cognitive function, however these studies have only considered the effects of the main intoxicating component of cannabis, THC. Here we will examine whether vaporized medicinal cannabis containing a 1:1 ratio of THC and CBD impairs driving in the same way as cannabis containing an equivalent amount of THC with no CBD. The novel study will examine real-world driving performance at various time points following consumption and examine driving in both urban and highway environments.

This is a collaboration between The Lambert Initiative at the University of Sydney, Royal Prince Alfred Hospital and Tilray.

Chief Investigators: Professor Jan Ramaekers (Maastricht University)

Project Coordinator: Thomas Arkell (Lambert Initiative, University of Sydney)